Cui, X. and Snapper, C.M. (2021) Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Frontiers in Immunology, 12, Article ID: 734471.
https://doi.org/10.3389/fimmu.2021.734471

has been cited by the following article:

• TITLE: Research Advances in Infectious Mononucleosis Caused by Epstein-Barr Virus

  AUTHORS: Yuying Wang, Peng Chen

  KEYWORDS: Epstein-Barr Virus, Infectious Mononucleosis, Children

  JOURNAL NAME: Open Journal of Pediatrics, Vol.14 No.1, January 22, 2024

  ABSTRACT: Infectious mononucleosis (IM), primarily caused by the Epstein-Barr virus (EBV), manifests as the classic triad of fever, pharyngitis, and cervical lymphadenopathy. Severe cases may involve organ damage, most commonly affecting the liver. Diagnosis relies on a combination of clinical presentation and laboratory parameters, with commonly used indicators including EBV-specific antibodies, EBV-DNA load, and the ratio of atypical lymphocytes. Treatment primarily involves symptomatic supportive care, with a cautious approach to the routine use of antiviral medications. In recent years, significant research in traditional Chinese medicine has been conducted in China, showing promising advancements. This article provides a comprehensive review of EBV-induced infectious mononucleosis, offering insights for clinical diagnosis and treatment.